ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Elevation Oncology Inc

Elevation Oncology Inc (ELEV)

0,8394
0,1756
(26,45%)
Fermé 07 Janvier 10:00PM
0,89
0,0506
(6,03%)
Après les heures de négociation: 1:59AM
Graphique avancé
Rendering Error

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
0,89
Prix Achat
0,87
Prix Vente
0,8998
Volume échangé
8 363 515
0,710001 Fourchette du Jour 0,9354
0,50 Plage de 52 semaines 5,8299
Cap du marché
Clôture Veille
0,6638
Ouverture
0,7384
Dernière Transaction
100
@
0.89
(formt)
Dernière heure de transaction
Volume financier
US$ 6 776 031
VWAP
0,810189
Volume moyen (3 m)
830 012
Actions en circulation
59 119 055
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,07
Bénéfice par action (BPA)
-0,77
Chiffre d'affairess
-
Bénéfice net
-45,7M

À propos de Elevation Oncology Inc

Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be th... Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition. Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Siège social
Camden, Delaware, USA
Fondé
-
Elevation Oncology Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker ELEV. Le dernier cours de clôture d'Elevation Oncology était de US$0,66. Au cours de la dernière année, les actions de Elevation Oncology ont été négociées dans une fourchette de prix de US$ 0,50 à US$ 5,8299.

Elevation Oncology compte actuellement 59 119 055 actions en circulation. La capitalisation boursière d'Elevation Oncology est de US$39,24 million. Elevation Oncology a un ratio cours/bénéfice (ratio PE) de -1.07.

ELEV Dernières nouvelles

Elevation Oncology Expands Pipeline with Nomination of EO-1022, a HER3 ADC for the Treatment of HER3-expressing Solid Tumors

Elevation Oncology Expands Pipeline with Nomination of EO-1022, a HER3 ADC for the Treatment of HER3-expressing Solid Tumors PR Newswire BOSTON, Dec. 12, 2024 -- EO-1022 is comprised of...

Elevation Oncology Presents Preclinical Proof-of-Concept Data Supporting Combination Potential of EO-3021 with VEGFR2 or PD-1 Inhibitors at ESMO Immuno-Oncology Annual Congress 2024

Elevation Oncology Presents Preclinical Proof-of-Concept Data Supporting Combination Potential of EO-3021 with VEGFR2 or PD-1 Inhibitors at ESMO Immuno-Oncology Annual Congress 2024 PR...

Elevation Oncology to Present at the Piper Sandler 36th Annual Healthcare Conference

Elevation Oncology to Present at the Piper Sandler 36th Annual Healthcare Conference PR Newswire BOSTON, Nov. 26, 2024 BOSTON, Nov. 26, 2024 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq:...

Elevation Oncology Reports Third Quarter 2024 Financial Results and Highlights Recent Business Achievements

Elevation Oncology Reports Third Quarter 2024 Financial Results and Highlights Recent Business Achievements PR Newswire BOSTON, Nov. 6, 2024 -- Promising initial Phase 1 data of EO-3021 reported...

Elevation Oncology Receives Fast Track Designation from the FDA for EO-3021 for the Treatment of Adult Patients with Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer Expressing Claudin 18.2

Elevation Oncology Receives Fast Track Designation from the FDA for EO-3021 for the Treatment of Adult Patients with Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer Expressing...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.2948.33333333330.60.89980.556314084630.6114387CS
40.2641.26984126980.630.89980.545111583120.6321793CS
120.3771.15384615380.520.89980.50828300120.60902818CS
26-1.99-69.09722222222.883.280.510201180.9548402CS
520.02382.747633341030.86625.82990.513982472.17890089CS
156-4.88-84.5753899485.776.8660.3637967922.51502618CS
260-13.11-93.64285714291416.220.3636869572.62300221CS

ELEV - Frequently Asked Questions (FAQ)

What is the current Elevation Oncology share price?
The current share price of Elevation Oncology is US$ 0,89
How many Elevation Oncology shares are in issue?
Elevation Oncology has 59 119 055 shares in issue
What is the market cap of Elevation Oncology?
The market capitalisation of Elevation Oncology is USD 39,24M
What is the 1 year trading range for Elevation Oncology share price?
Elevation Oncology has traded in the range of US$ 0,50 to US$ 5,8299 during the past year
What is the PE ratio of Elevation Oncology?
The price to earnings ratio of Elevation Oncology is -1,07
What is the reporting currency for Elevation Oncology?
Elevation Oncology reports financial results in USD
What is the latest annual profit for Elevation Oncology?
The latest annual profit of Elevation Oncology is USD -45,7M
What is the registered address of Elevation Oncology?
The registered address for Elevation Oncology is 2140 S DUPONT HWY, KENT, CAMDEN, DELAWARE, 19934
What is the Elevation Oncology website address?
The website address for Elevation Oncology is www.elevationoncology.com
Which industry sector does Elevation Oncology operate in?
Elevation Oncology operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
BOXLBoxlight Corporation
US$ 1,645
(257,61%)
240,38M
SPRCSciSparc Ltd
US$ 1,06
(100,80%)
190,41M
XTIAXTI Aerospace Inc
US$ 0,08261
(99,54%)
1,56B
DHAIDIH Holdings US Inc
US$ 2,8602
(82,18%)
4,67M
NXPLNextPlat Corporation
US$ 1,73
(61,68%)
12,6M
RGFReal Good Food Company Inc
US$ 1,31
(-63,49%)
1,47M
LUNALuna Innovations Incorporated
US$ 0,8744
(-57,35%)
12,29M
GCTKGlucoTrack Inc
US$ 0,1594
(-45,65%)
35,76M
ACONAclarion Inc
US$ 0,1699
(-43,06%)
35,05M
BLRXBioLineRx Ltd
US$ 0,1621
(-40,80%)
44,6M
XTIAXTI Aerospace Inc
US$ 0,08261
(99,54%)
1,56B
NVDANVIDIA Corporation
US$ 149,43
(3,43%)
256,79M
CNSPCNS Pharmaceuticals Inc
US$ 0,11987
(-2,54%)
243,9M
BOXLBoxlight Corporation
US$ 1,645
(257,61%)
240,37M
SPRCSciSparc Ltd
US$ 1,06
(100,80%)
189,16M

ELEV Bilan

Bilan
Rendering Error
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock